Sponsor Collaborators Module

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Sponsor Collaborators Module

The Sponsor Collaborators Module contains information about the sponsors and collaborators involved in the clinical trial. This includes lead sponsor details, responsible party information, investigator information, and collaborator organizations that are supporting or conducting the study.

Sponsor Collaborators Module path is as follows:

Study -> Protocol Section -> Sponsor Collaborators Module -> Collaborators

Sponsor Collaborators Module

Ignite Creation Date: 2025-12-24 @ 2:32 PM
Ignite Modification Date: 2025-12-25 @ 1:05 PM
NCT ID: NCT03725059
Responsible Party Type: SPONSOR
Study: NCT03725059
Study Brief: Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
Protocol Section: NCT03725059
Collaborators (If Any):